Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 24 (NPM1P24)

Target
NPM1P24
Molecular classification
Other
01

Overview

Nucleophosmin 1 pseudogene 24 (NPM1P24) is a pseudogene, which means it is a non-functional segment of DNA resembling the protein-coding gene NPM1. Pseudogenes such as NPM1P24 typically do not encode functional proteins, do not serve as classical drug targets, and generally lack described biological activity or involvement in disease processes. Most databases and the scientific literature do not list NPM1P24 as a therapeutic target, receptor, enzyme, transporter, or regulator, and there is no evidence of clinical or pharmacological relevance. Any reference to NPM1P24 as a therapeutic target is likely mistaken or confusing it with the functional NPM1 gene, which is relevant in contexts such as acute myeloid leukemia[4]. Key clarifications: - NPM1P24 is a pseudogene, not an active gene or receptor. - The functional gene NPM1 (Nucleophosmin 1) is well-studied, especially in cancer biology, but NPM1P24 shares no such established relevance[4]. - No drugs, mechanisms, or disease associations are described for NPM1P24. Any reference otherwise is likely inaccurate or conflated with NPM1. If your query intended to refer to the *Nucleophosmin 1* gene or protein (NPM1), please clarify, as this is an important oncogenic target with significant roles in hematologic malignancy.

Other names
NPM1P24

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 24 (NPM1P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 24 (NPM1P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call